Chronic obstructive pulmonary disease and bronchial asthma
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. COPD or bronchial asthma patients who are planning to switch to single-inhaler triple therapy
Exclusion criteria
Exclusion criteria: 1. Patients with airway infection within 3 months 2. Patients who are contraindicative for single-inhaler triple therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| A change of FEV1 after 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| A change of symptom score, FVC, IC, respiratory impedance, FeNO after 8 weeks | — |
Countries
Japan
Contacts
Shizuoka General Hospital Respiratory medicine